Nicolas Collongues

Strasbourg, 67000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 138 publications

Integrative Transcriptomic Analysis Reveals Impaired Oligodendrocyte Maturation and Myelination Signature in the Hippocampus of a Murine Model of Neuropsychiatric Lupus.

Integrative Transcriptomic Analysis Reveals Impaired Oligodendrocyte Maturation and Myelination Signature in the Hippocampus of a Murine Model of Neuropsychiatric Lupus.

Journal: International journal of molecular sciences

Published: July 26, 2026

Suspected ICANS in systemic sclerosis: think twice before corticosteroids.

Suspected ICANS in systemic sclerosis: think twice before corticosteroids.

Journal: Rheumatology (Oxford, England)

Published: June 15, 2026

Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.

Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.

Journal: Annals of clinical and translational neurology

Published: June 12, 2026

French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.

French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.

Journal: Neurology

Published: May 22, 2026

News in autoimmune myelitis in the oncological context.

News in autoimmune myelitis in the oncological context.

Journal: Current opinion in neurology

Published: April 28, 2026

French guidelines for the diagnosis and management of neuromyelitis optica spectrum disorder.

French guidelines for the diagnosis and management of neuromyelitis optica spectrum disorder.

Journal: Revue neurologique

Published: April 10, 2026

Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS.

Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS.

Journal: Neurology

Published: April 01, 2026

Treatment Discontinuation in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Treatment Discontinuation in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: JAMA neurology

Published: March 23, 2026

A Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing-Remitting Multiple Sclerosis.

A Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing-Remitting Multiple Sclerosis.

Journal: Neurology and therapy

Published: March 12, 2026

Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis.

Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis.

Journal: Neurology and therapy

Published: March 05, 2026

Place of anti-IL6R in the therapeutic strategy in NMOSD-AQP4+, MOGAD, and NMOSD double-seronegative patients.

Place of anti-IL6R in the therapeutic strategy in NMOSD-AQP4+, MOGAD, and NMOSD double-seronegative patients.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 17, 2025

French guidelines for the diagnosis and management of MOG antibody-associated disease.

French guidelines for the diagnosis and management of MOG antibody-associated disease.

Journal: Revue neurologique

Published: February 18, 2025

Showing 1-12 of 138

Last Updated: 09/26/2026